深度创新：解决人类难 题需要更多付出 The introductory article to the issue introduces the class of heavy duty ventures we term “Deep Innovation”: those that are enabled by basic research or a scientific breakthrough, and that  usually require substantial resources and 5–20 years to materialize as a commercial success – if they do at all. These innovations often solve big problems that can transform our …

波士顿医学与创新技术融合中 心(CIMIT)的医学领域深度创新 机构案例研究 Today’s Healthcare field is facing major crises, including the aging of the population, the need to increase access for all to the best standard of care, and societal imperatives to contain healthcare-related costs. Unfortunately there are many challenges to innovation in this domain. This article showcases CIMIT, the Consortia for Improving Medicine with Innovation & Technology, a Boston-based cooperation …

深度创新与大脑科技初创企业 专业领域案例研究 The gap is alarming: while “The plague of the 21st century is rooted in the brain. Nearly 100 million Americans suffer from CNS disorders, resulting in an annual economic cost of over $760 billion”, we read that “six of the ten largest pharmaceutical companies have sharply reduced their CNS-targeted drug development efforts”. Dr. Bar-On’s  article deals with the unique …

深度创新与制药初创企业 专业领域案例研究 While there is no doubt about the benefit to humanity of pharmaceutical innovation, it remains a fact that new medicines are notoriously difficult to get into the hands of the people that need them so badly. Mr. Waisbourd, a vice president in the R&D division of a world leading pharma company, focuses in this article on what he terms …

深度创新与制药初创企业 专业领域案例研究 This article takes an original approach to examine corporate strategies related to the creation, recombination and integration of the scientific and technological knowledge that enables them to pursue Deep Innovation in the exciting new field of Graphene nanotechnology. The authors analyzed the patent portfolios of 14 leading firms, and characterized them according to the origins and nature of the …